ROS-activated compounds as selective anti-cancer therapeutics
申请人:University of Cincinnati
公开号:US09394233B2
公开(公告)日:2016-07-19
Provided are compounds according to the following Formula I:
The Formula I compounds are activated in the presence of reactive oxygen species (ROS) and are therefore selective anti-cancer therapeutics for cancers associated with elevated ROS. Also provided are methods and pharmaceutical compositions for treating cancers associated with increased ROS.